Pharmacists outline new oncologic therapeutics, from pancreatic cancer to myeloma, and what high prices and crowded markets mean for payers.
Commentary|Podcasts|September 19, 2024
Exploring Consumer Perspectives on Network Adequacy Definitions
Author(s)Brooke McCormick
On this episode of Managed Care Cast, we're talking with the author of a study published in the September 2024 issue of The American Journal of Managed Care® that explored the factors consumers consider essential for an adequate provider network.
Advertisement
On this episode of Managed Care Cast, we're talking with Simon F. Haeder, PhD, MPA, associate professor of public health at Texas A&M University.
His
Listen above or on one of these podcast services:
Advertisement
Related to this article
Erythema-based criteria miss skin of color, urging ROSCO phenotyping to improve diagnostic equity in dermatology.
Bipolar disorder often goes undiagnosed for years, and clinicians need to separate mood episodes from normal emotions and keep patients on treatment.
Norah Terrault, MD, MPH, on why few diagnosed patients reach HCV cure and how primary care test-and-treat can close the gap.
Initial frontal fibrosing alopecia treatment was largely similar in Black and White patients, though tetracycline use was higher in Black patients.
Patients with Sjögren disease have 5-fold higher odds of depression, yet screening tools remain unvalidated, a new review finds.
Patient selection raised detection of pathogenic germline variants from 6% to 27% in lung cancer studies.
Many patients who stop a GLP-1 RA regain weight. How plans can measure adherence when cash-pay fills go unseen.
Advertisement
Advertisement
Trending on AJMC
1
Occasional Cannabis Use Linked to 40% Higher Odds of Stroke
2
Enlicitide LDL-C Lowering Holds Across Risk Levels Up to 2 Years
3
GLP-1 Use Tied to Lower Diabetes, CV Risk vs Metformin in Prediabetes
4
Invivyd Unveils Measles Antibody Candidate VMS063 at IDWeek 2026
5